Medtronic (MDT) Liabilities from Discontinued Operations (2017)
Medtronic's (MDT) quarterly Liabilities from Discontinued Operations came in at 59000000.0 in Q3 2017, up 73.53% quarter-over-quarter from 34000000.0 in Q2 2017.
Medtronic (MDT) Liabilities from Discontinued Operations (2017) Analysis & Trends
Medtronic has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting 59000000.0 for Q3 2017.
- Liabilities from Discontinued Operations for Q3 2017 came in at 59000000.0, changed N/A year-over-year; the trailing twelve-month figure through Jul 2017 was 59000000.0 (changed N/A YoY), and the FY2017 annual result was 34000000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at 59000000.0 for Q3 2017 at Medtronic, up from 34000000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 59000000.0 in Q3 2017 to a low of 34000000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 28, 2017 | 59.00 Mn |
| Jul 28, 2017 | 59.00 Mn |
| Apr 28, 2017 | 34.00 Mn |
| Apr 28, 2017 | 34.00 Mn |